Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Subcutaneous anti-HLA-DR monoclonal antibody for treatment of hematologic malignancies

Subcutaneous anti-HLA-DR monoclonal antibody for treatment of hematologic malignancies

US Patent 11180559 · Granted Nov 23, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for hemoclip deployment2025
Charging device for electrically operated vehicles and method2025
Tool for hemostasis and tissue approximation2025
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and de2025
Antibody-drug conjugates and uses thereof2025
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and de2025
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and de2023
Synergistic effect of anti-trop-2 antibody-drug conjugate in combination therapy2022
Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PAR2022
Efficacy of anti-Trop-2-SN-38 antibody drug conjugates for therapy of tumors rel2021
Immunoconjugates with an intracellularly-cleavable linkage2021
Antibody-drug conjugates and uses thereof2021